Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer
Open Access
- 30 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11), e51056
- https://doi.org/10.1371/journal.pone.0051056
Abstract
Onco-miR-182-5p has been reported to be over-expressed in bladder cancer (BC) tissues however a detailed functional analysis of miR-182-5p has not been carried out in BC. Therefore the purpose of this study was to: 1. conduct a functional analysis of miR-182-5p in bladder cancer, 2. assess its usefulness as a tumor marker, 3. identify miR-182-5p target genes in BC. Initially we found that miR-182-5p expression was significantly higher in bladder cancer compared to normal tissues and high miR-182-5p expression was associated with shorter overall survival in BC patients. To study the functional significance of miR-182-5p, we over-expressed miR-182-5p with miR-182-5p precursor and observed that cell proliferation, migration and invasion abilities were increased in BC cells. However cell apoptosis was inhibited by miR-182-5p. We also identified Smad4 and RECK as potential target genes of miR-182-5p using several algorithms. 3′UTR luciferase activity of these target genes was significantly decreased and protein expression of these target genes was significantly up-regulated in miR-182-5p inhibitor transfected bladder cancer cells. MiR-182-5p also increased nuclear beta-catenin expression and while Smad4 repressed nuclear beta-catenin expression. In conclusion, our data suggests that miR-182-5p plays an important role as an oncogene by knocking down RECK and Smad4, resulting in activation of the Wnt-beta-catenin signaling pathway in bladder cancer.Keywords
This publication has 44 references indexed in Scilit:
- Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder CancerBMC Urology, 2012
- Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of β-CateninGastroenterology, 2012
- Involvement of the SKP2–p27KIP1 pathway in suppression of cancer cell proliferation by RECKOncogene, 2011
- Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical CancerClinical Cancer Research, 2011
- Biomarkers in bladder cancerHistopathology, 2010
- MicroRNA control of signal transductionNature Reviews Molecular Cell Biology, 2010
- Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitroCancer Research, 2009
- Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.2008
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Characteristics of invasive bladder cancers: histological and molecular markers.1996